TB Therapy

Universal DOT: Necessary Strategy or Waste of Resources?

Published in TB and Outbreaks Week, October 25th, 1999

In recent years few have questioned the belief that directly observed therapy is a superior strategy for controlling the spread of tuberculosis.

But that may be changing.

Researchers have begun to wonder aloud whether directly observed therapy (DOT), and especially universal DOT, is the best use of limited tuberculosis funding.

In a recent editorial, L. Peter Ormerod of the United Kingdom's University of Central Lancashire asked whether the data supporting the superior efficacy of DOT are being misinterpreted. He noted that DOT programs tend to have greater economic resources that may positively influence factors independent of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1999-10-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry